Management of Methimazole-Induced Agranulocytosis
Do NOT start propylthiouracil (PTU) – switching to the alternative antithyroid drug is absolutely contraindicated due to cross-reactivity risk. 1
Immediate Actions
1. Stop Methimazole Immediately
- Discontinue methimazole as soon as agranulocytosis is confirmed (ANC <500 cells/µL)
- Both methimazole and PTU are contraindicated once agranulocytosis develops with either agent 1, 2
2. Obtain Urgent Laboratory Studies
- Complete blood count with differential
- Blood cultures if febrile
- Throat culture if pharyngitis present
- Liver function tests 1, 3
3. Initiate Supportive Care
- Broad-spectrum IV antibiotics if fever or infection present (even without documented source) 3, 4, 5
- Granulocyte colony-stimulating factor (G-CSF) to accelerate neutrophil recovery – reduces duration of agranulocytosis from ~10-13 days to 3-7 days 3, 4, 6
- Reverse isolation precautions
- Monitor for sepsis/septic shock 3
Bridging Therapy for Hyperthyroidism Control
Since antithyroid drugs are contraindicated, use the following combination:
Beta-Blockade
- Propranolol 20-40 mg every 6 hours OR atenolol 25-50 mg daily
- Controls tachycardia, tremor, and peripheral symptoms
- Use cardioselective agents if reactive airway disease present 1, 3
Saturated Solution of Potassium Iodide (SSKI)
- 3-7 drops (0.15-0.35 mL) three times daily for 10-14 days maximum
- Blocks thyroid hormone release acutely
- Can be used for up to 29 days in severe cases, though escape phenomenon typically occurs after 10-14 days 1, 3, 7
- Alternative: Lugol's solution 5-7 drops (0.25-0.35 mL) three times daily 1, 7
Additional Bridging Options
- Cholestyramine 4 g three times daily – binds thyroid hormones in enterohepatic circulation, accelerates clearance 3, 8
- Corticosteroids (hydrocortisone 100 mg IV every 8 hours or dexamethasone 2 mg every 6 hours) – blocks T4 to T3 conversion and provides stress-dose coverage 3, 8
- Lithium 300 mg three times daily (rarely used, requires monitoring) 3
- Plasmapheresis for refractory thyroid storm 3
Definitive Management
Proceed to definitive therapy urgently – agranulocytosis eliminates medical management as a long-term option:
Radioactive Iodine (RAI)
- Preferred if patient is stable and not severely thyrotoxic
- Must wait until neutrophil recovery (typically 7-14 days with G-CSF)
- Continue bridging therapy until RAI takes effect (6-12 weeks) 1
Total Thyroidectomy
Indicated if:
Surgical preparation:
Critical Pitfalls to Avoid
Never switch to PTU – cross-reactivity occurs in agranulocytosis and other serious reactions; risk of recurrent agranulocytosis is high 1, 6
Do not delay definitive therapy – agranulocytosis typically resolves in 3-13 days with G-CSF, but antithyroid drugs remain permanently contraindicated 4, 5
Avoid prolonged iodine therapy – escape phenomenon occurs after 10-14 days; use only as bridge to definitive treatment 3
Do not restart methimazole – even at low doses after apparent tolerance, agranulocytosis can recur and may be more severe 9
Monitoring During Recovery
- Daily CBC until ANC >1000 cells/µL, then every 2-3 days until normal 4, 5
- Thyroid function tests every 4-6 weeks during bridging therapy 1
- Clinical assessment for infection daily
- Cardiac monitoring if heart failure or arrhythmias present 7